Information  X 
Enter a valid email address

Karolinska Development AB (pub (0P3C)

  Print   

Wednesday 20 December, 2017

Karolinska Development AB (pub

Karolinska Development's portfolio company Modus Therapeutics announces publication of Phase I/II data demonstrating anti-adhesive properties of sevuparin

YASTEST

a d v e r t i s e m e n t